Plain-English translation of NCT07019896 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer surgical approach called Minimal Vitrectomy Surgery (MVS) works as well as or better than standard vitrectomy surgery for treating epiretinal membrane — a condition where scar tissue grows on the back of your eye and causes blurred or distorted vision. The new technique aims to remove the scar tissue while preserving more of the eye's natural structures, which may reduce the risk of cataract development after surgery.
Standard surgery for epiretinal membrane involves removing a significant amount of fluid from inside the eye, which can increase the risk of developing cataracts later. This trial exists to see if a gentler surgical approach can treat the scar tissue effectively while protecting your natural lens.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either the new Minimal Vitrectomy Surgery or standard vitrectomy surgery to remove the scar tissue from your retina. After your surgery, you will have follow-up visits where doctors will check your vision, measure the thickness of your retina, and look for any signs of cataract development or scar tissue returning. The trial will track your results over time to compare how well the two approaches work.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China
Sponsor
Peking Union Medical College Hospital
Collaborators
Peking Union Medical College
Enrollment target
~140 participants
Started
December 2024
Primary completion
November 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Weihong Yu, MD
Peking Union Medical College Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.